ThyCalc

com.thycalc

View detailed information for ThyCalc — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
310(310)
Rating
0.0
Released
February 20, 2020
Last updated
June 6, 2020
Category
Medical
Developer
Paula Bavcar
Developer details
Name
Paula Bavcar
E-mail
paulabavcar@gmail.com
Website
unknown
Country
unknown
Address
unknown
Android SDKs
ThyCalc Header - AppWisp.com

Screenshots

ThyCalc Screenshot 1 - AppWisp.com
ThyCalc Screenshot 2 - AppWisp.com
ThyCalc Screenshot 3 - AppWisp.com
ThyCalc Screenshot 4 - AppWisp.com

Description

ThyCalc guides the Medical Doctor through the American Joint Committee on Cancer (AJCC) guide to calculate TNM and recurrence risk following the American Thyroid association (ATA) guide or the Argentinean society of endocrinology and metabolism (SAEM) guide.

ThyCalc DOES NOT provide any information about treatments nor drug doses. Such decisions are left for the Medical Doctor criteria.

**** WARNING ****
This app is to be used by Medical Doctors only.
Reliance on information provided by this application is solely at your own risk.
This app does not provide information about treatment or studies patients should do, treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances.
A calculator is not intended to take place of physician judgment in diagnosing and treatment of particular patients.
Errors could occur, and feedback is greatly appreciated if you notice any, and will be revised as soon as possible.
The authors disclaim responsibility for any injury to persons resulting from the use of this app.

**** SOURCES OF INFORMATION ****

The calculations made by ThyCalc are product of scientific research compiled by the American Joint Committee on Cancer (AJCC), the American Thyroid association (ATA) and the Argentinean society of endocrinology and metabolism (SAEM).

The sources can be found here:

TNM: https://cancerstaging.org/About/news/Pages/AJCC-8th-Edition-Cancer-Staging-Form-and-Histology-and-Topography-Supplements-Available-Now.aspx

Recurrence Risk by ATA: https://www.thyroid.org/professionals/ata-professional-guidelines/

Recurrence Risk by SAEM: https://www.saem.org.ar/noticias/consenso-2014.pdf